#Sustainability #EcoVadis #Switzerland #Solvias #Kaiseraugst

Solvias Achieves Notable Sustainability Assessment from EcoVadis

In a significant milestone for sustainable business practices, Solvias, a leading international provider of Chemistry, Manufacturing & Control (CMC) analytics, announced that it has earned a committed badge from EcoVadis, following a comprehensive initial assessment. This recognition places Solvias among the top performers, evaluated alongside over 100,000 companies for their sustainability efforts.

The accolade comes as a testament to Solvias' unwavering commitment to incorporating Environmental, Social, and Governance (ESG) principles into its core operations. Since launching its ESG initiative in 2024, the company has made remarkable strides in establishing a robust sustainability framework. Solvias has calculated its carbon footprint, set clear sustainability objectives, and developed an extensive five-year action plan aimed at reducing environmental impact and fostering meaningful change.

The positive EcoVadis assessment serves as a solid foundation for Solvias to further enhance its sustainability initiatives. To solidify its commitment, the company is set to formally align with the Science Based Targets initiative (SBTi) in the coming months. This global organization assists companies in cutting greenhouse gas emissions, reinforcing Solvias' long-term strategy for promoting sustainability.

Archie Cullen, CEO of Solvias, stated, "Receiving our first EcoVadis assessment is a crucial milestone that validates our progress and sharpens our focus on driving impactful change. We take pride in what we have achieved and remain wholly dedicated to integrating sustainability effectively into our business operations."

With an active five-year plan already underway, Solvias is taking substantial steps toward achieving its sustainability goals. These initiatives are targeted at continuous improvement, higher ratings, and measurable contributions to a more sustainable future.

About Solvias

Solvias is a global provider of analytics in the realm of chemistry, manufacturing, and control (CMC) dedicated to the biosciences industry. The expert team merges decades of experience with regulatory expertise in small molecules, biologics, and cell and gene therapies. Solvias offers end-to-end solutions ranging from raw material testing to drug release and active pharmaceutical ingredient (API) development for small molecules.

Headquartered near Basel, Switzerland, Solvias operates six global Centers of Excellence, all adhering to the highest ISO, GMP, GLP, and FDA standards. To learn more about their offerings and commitment to sustainability, visit solvias.com.

Media Contact
Katy McGirr
Director of International Marketing
[corporate email]
+1 617 513 8287